Value of global oncology drugs market.... my69z
Post# of 154612
(Total Views: 862)
Posted On: 05/10/2025 7:31:10 PM
Value of global oncology drugs market....
my69z
Apr 03, 2025 8:18 PM
$CYDY
The global oncology drugs market is expected to reach $532.91 billion by 2031.
___
Leronlimab:
Non-toxic, shrinks tumors, blocks angiogenesis & metastatic process, when continued alive & well cancer-free -- future SOC?
( all chips in @ yes )
___
The global anti-inflammatory drugs market size was valued at USD 120.46 billion in 2023 and is anticipated to reach around USD 272.35 billion by 2033
The 2 drug markets Cytodyn has kept in-house: $800B dollars.
___
Now add May 7th, 2025:
Add alive @ 42, 48, 49 & 52 months....Cancer-free
___
& $1T when add autoimmune to the 2 indications:
my69z
Apr 07, 2025 11:15 PM
$CYDY Inflammation is a central feature of autoimmune diseases. It is caused by the body's immune system attacking its own tissues, leading to chronic damage and various symptoms. Understanding and managing inflammation is crucial for treating and preventing the complications of autoimmune disorders.
The Autoimmune Disease Therapeutics Market grew from USD 214.65 billion in 2024 to USD 231.15 billion in 2025.
Google says GSK / Pfizer / Gilead top 3.
2023 Humiria top seller.
___
42, 48, 49 & 52 months....Cancer-free
Use a low LL 20% market penetration of $1T.
÷ by 1.5b shares outstanding.
Apply a 10x multiple.
___
Above is before adding Long Acting Leronlimab.
my69z
Apr 03, 2025 8:18 PM
$CYDY
The global oncology drugs market is expected to reach $532.91 billion by 2031.
___
Leronlimab:
Non-toxic, shrinks tumors, blocks angiogenesis & metastatic process, when continued alive & well cancer-free -- future SOC?
( all chips in @ yes )
___
The global anti-inflammatory drugs market size was valued at USD 120.46 billion in 2023 and is anticipated to reach around USD 272.35 billion by 2033
The 2 drug markets Cytodyn has kept in-house: $800B dollars.
___
Now add May 7th, 2025:
Add alive @ 42, 48, 49 & 52 months....Cancer-free
___
& $1T when add autoimmune to the 2 indications:
my69z
Apr 07, 2025 11:15 PM
$CYDY Inflammation is a central feature of autoimmune diseases. It is caused by the body's immune system attacking its own tissues, leading to chronic damage and various symptoms. Understanding and managing inflammation is crucial for treating and preventing the complications of autoimmune disorders.
The Autoimmune Disease Therapeutics Market grew from USD 214.65 billion in 2024 to USD 231.15 billion in 2025.
Google says GSK / Pfizer / Gilead top 3.
2023 Humiria top seller.
___
42, 48, 49 & 52 months....Cancer-free
Use a low LL 20% market penetration of $1T.
÷ by 1.5b shares outstanding.
Apply a 10x multiple.
___
Above is before adding Long Acting Leronlimab.
(14)
(0)